Systemic MSC infusion is the quieter side of regenerative medicine. Delivered intravenously, it works everywhere at once. For patients moving from reactive care to proactive maintenance: recovery, inflammation, performance, resilience.
Systemic MSC therapy isn't one protocol. We tailor dose, cadence, and adjuncts to the reason you walk in.
You're 45–70, feel "fine," and want to stay ahead of decline. Inflammation markers are creeping. Sleep is slipping. Recovery takes longer than it used to. MSC maintenance is the systemic upstream move.
Training volume is high and the body is signaling. Soft-tissue niggles, chronic low-grade tendinopathy, slower return-to-train. You need faster clearance of inflammatory load without steroids that blunt adaptation.
You're recovering from a major surgery, a serious illness, or a systemic event (long COVID, chemo, cardiac procedure). You want the fastest honest path back to baseline function, cleared through your primary physician.
IV-delivered MSCs are not "pumped into a joint." They circulate. Most transit the lungs first (which is where they do some of their most interesting work) and from there signal throughout the body.
Screened allogeneic MSCs suspended in a small volume of saline, delivered through a peripheral IV over ~45 minutes.
Most cells transit the pulmonary capillary bed first. Residence time here is hours, and where a large share of immunomodulatory signaling occurs.
Cells traffic to sites of inflammation, ischemia, and tissue stress, attracted by cytokine gradients released by damaged tissue.
Cells release extracellular vesicles and growth factors that modulate local immune response, reduce inflammation, and support resident repair cells.
MSCs are cleared within ~14 days. The therapeutic window extends longer, driven by downstream effects on the body's own repair machinery.
NOTE This is a simplified model. MSC behavior in vivo remains an active research area, and clinical benefit is not fully explained by any single mechanism. We describe what we observe and what the literature supports.
Same methodology as our joint program, different numbers. No anesthesia, no procedure room, no recovery time. You arrive, infuse, leave.
Comprehensive blood work: CBC, CMP, inflammatory markers (CRP, IL-6), ApoB, HOMA-IR, HbA1c. Sleep, HRV, and symptom questionnaire. Baseline we can measure against.
Arrival, updated vitals, IV placement by our infusion RN. Private infusion suite. You'll be awake, comfortable, and can work or read.
Cells drawn from cryopreservation, warmed and suspended in saline, infused at a controlled rate over ~45 minutes. Vitals monitored throughout. Sensations are typically nothing beyond mild warmth.
Short observation, hydration, discharge instructions. Most patients leave within 30 minutes of the infusion ending.
Same biomarker panel repeated at 60 and 90 days. We compare deltas against baseline and co-author the next-cycle plan. If there's no measurable response, we don't schedule another infusion.
A realistic timeline, infusion day through 6 months, of what IV recipients typically report. Not everyone follows this curve, and we tell you when yours is outside it.
Mild warmth as the infusion runs. Occasional brief flush. Nothing dramatic. This is a quiet procedure by design.
Some patients describe a brief "activation": mild fatigue, slightly elevated temperature, vivid sleep. Typically subsides by day 3.
Sleep quality and recovery first. Small things: legs heavier for less time after training, calmer inflammation, fewer minor aches.
Inflammatory markers trend down on re-draw. HRV often up. Subjective energy and cognitive clarity reports peak here for most patients.
Re-measurement panel. We decide together: maintain, extend cadence, or conclude this cycle. No automatic re-bookings.
Aggregated from the current IV cohort. These are biomarker and symptom deltas, not "feel" reports. Individual results vary; we measure and publish both.
***Note Outcome figures are placeholder values for design purposes. Final site will display registry-verified numbers updated quarterly.
Includes consult, full biomarker panels, MSC infusion, concierge transport from San Diego, and structured follow-up. Most patients return two to four times per year. Exact figure confirmed after the physician evaluation.
Pricing includes concierge transport from San Diego, full biomarker panels, and follow-up. We do not take insurance. Adjunct stacks (NAD+, glutathione, peptides) priced separately.
See full pricing matrix →For patients who want the detailed read on cadence, the day-of experience, durability, and the joint-therapy add-on. One page per topic.
Begin with a single discovery visit. Full baseline panel, one infusion, a protocol we build together. If it's not delivering measurable signal at 90 days, we say so. And we don't book the next one.